Cover Image
市場調查報告書

藥物成癮:全球臨床實驗檢討

Drug Addiction Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 306662
出版日期 內容資訊 英文 76 Pages
訂單完成後即時交付
價格
Back to Top
藥物成癮:全球臨床實驗檢討 Drug Addiction Global Clinical Trials Review, H1, 2014
出版日期: 2014年06月20日 內容資訊: 英文 76 Pages
簡介

本報告提供藥物成癮相關的臨床研究最新趨勢分析,為您彙整疾病治療方法概要,及臨床實驗的主要國家──G7各國及E7(新興7國)的臨床實驗數及實驗對象採用狀況,地區、Phase、階段別的進展,有潛力的贊助商,各企業研究機關的研究進展,有潛力的藥劑比較等資訊。

目錄

簡介

  • 藥物成癮
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東及非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統疾病臨床實驗數量中,藥物成癮臨床實驗數量比例

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7(新興7個國家)各國臨床實驗數量:中樞神經系統疾病臨床實驗數量中,藥物成癮臨床實驗數量比例

E7(新興7個國家)各國臨床實驗數量:Phase別

E7(新興7個國家)各國臨床實驗數量:各進展狀況

Phase別臨床實驗數量

  • 進行中的臨床實驗:不同階段

各進展狀況臨床實驗數量

試驗指標達成狀況別臨床實驗數量

尚未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

有潛力的藥劑

藥物成癮的最新臨床實驗資訊

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • RTI International
    • Johnson & Johnson
    • Alkermes Inc. (Inactive)
    • SK Holdings Co., Ltd.
    • Reckitt Benckiser Group Plc
    • GlaxoSmithKline plc
    • Embera NeuroTherapeutics, Inc.
    • Catalyst Pharmaceutical Partners, Inc.
    • Gilead Sciences, Inc.
    • D&A Pharma SAS
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Institute on Drug Abuse
    • Yale University
    • University of Pennsylvania
    • New York State Psychiatric Institute
    • University of California, Los Angeles
    • Johns Hopkins University
    • Medical University of South Carolina
    • Baylor College of Medicine
    • University of Arkansas
    • University of Kentucky

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2213CTIDB

GlobalData's clinical trial report, "Drug Addiction Global Clinical Trials Review, H1, 2014" provides data on the Drug Addiction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Drug Addiction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Drug Addiction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Drug Addiction
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Drug Addiction to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Drug Addiction to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Drug Addiction
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Drug Addiction Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Drug Addiction
    • May 27, 2014: Biotie: nepicastat study in cocaine dependence completes enrollment ahead of schedule - top-line data expected around end 2014
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • RTI International
      • Clinical Trial Overview of RTI International
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Alkermes Inc. (Inactive)
      • Clinical Trial Overview of Alkermes Inc. (Inactive)
      • SK Holdings Co., Ltd.
      • Clinical Trial Overview of SK Holdings Co., Ltd.
      • Reckitt Benckiser Group Plc
      • Clinical Trial Overview of Reckitt Benckiser Group Plc
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Embera NeuroTherapeutics, Inc.
      • Clinical Trial Overview of Embera NeuroTherapeutics, Inc.
      • Catalyst Pharmaceutical Partners, Inc.
      • Clinical Trial Overview of Catalyst Pharmaceutical Partners, Inc.
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
      • D&A Pharma SAS
      • Clinical Trial Overview of D&A Pharma SAS
    • Clinical Trial Overview of Top Institutes / Government
      • National Institute on Drug Abuse
      • Clinical Trial Overview of National Institute on Drug Abuse
      • Yale University
      • Clinical Trial Overview of Yale University
      • University of Pennsylvania
      • Clinical Trial Overview of University of Pennsylvania
      • New York State Psychiatric Institute
      • Clinical Trial Overview of New York State Psychiatric Institute
      • University of California, Los Angeles
      • Clinical Trial Overview of University of California, Los Angeles
      • Johns Hopkins University
      • Clinical Trial Overview of Johns Hopkins University
      • Medical University of South Carolina
      • Clinical Trial Overview of Medical University of South Carolina
      • Baylor College of Medicine
      • Clinical Trial Overview of Baylor College of Medicine
      • University of Arkansas
      • Clinical Trial Overview of University of Arkansas
      • University of Kentucky
      • Clinical Trial Overview of University of Kentucky
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Drug Addiction Therapeutics, Global, Clinical Trials by Region, 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Drug Addiction Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Drug Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Drug Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Drug Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Drug Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Drug Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Drug Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Drug Addiction Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Drug Addiction Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Drug Addiction Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Drug Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by RTI International, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Alkermes Inc. (Inactive), 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by SK Holdings Co., Ltd., 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Reckitt Benckiser Group Plc, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Embera NeuroTherapeutics, Inc., 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Catalyst Pharmaceutical Partners, Inc., 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by D&A Pharma SAS, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Drug Abuse, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by New York State Psychiatric Institute, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of South Carolina, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Arkansas, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2014*

List of Figures

  • Drug Addiction Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Drug Addiction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Drug Addiction Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Drug Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Drug Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Drug Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Drug Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Drug Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Drug Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Drug Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Drug Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top